Revolutionising respiratory health: inhalation drug product testing
It’s estimated that around 545 million individuals worldwide live with chronic respiratory conditions. Given its prevalence, inhalation therapeutics are an integral focus within the R&D realm to evolve treatments. With inhalation pharmaceutical developments comes a comprehensive range of testing methods and tools, used to validate and qualify each new product as safe and viable and…
Read more